Kendall Park, NJ, United States of America

Atul S Kotnis

This inventor holds 4 USPTO granted patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2001-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atul S Kotnis. Retrieved from https://idiyas.com/inventor/atul-s-kotnis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 8.7

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2001-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Atul S. Kotnis: Pioneering Chemical Processes

Introduction

Atul S. Kotnis, an accomplished inventor based in Kendall Park, NJ, has made significant contributions to the field of chemistry with a total of four patents. His innovative work primarily focuses on enhancing synthesis processes and optimizing chemical reactions, reflecting his expertise and commitment to advancing the industry.

Latest Patents

Among his recent patents are two noteworthy advancements:

1. **Dynamic Resolution of Isomers**

This invention presents a dynamic resolution method aimed at enriching the desired isomer of an alpha-substituted carboxylic acid over its undesired counterpart. The process involves several key steps: contacting the alpha-substituted carboxylic acid with a homochiral amine to form an insoluble salt under selected conditions, followed by reacting this salt with a nucleophile to achieve an increase in the less soluble amine salt of the desired isomer. The method is tailored to enhance the production of the desired alpha-substituted carboxylic acid isomer effectively.

2. **Process for Hydroxyazapirones**

This patent details a process for synthesizing hydroxyazapirones from azapirones. The method encompasses treating azapirones with a strong base, monitoring enolate formation via IR spectroscopy, and subsequently reacting the enolate with a molecular oxygen source in the presence of a reductant. This innovative process is designed for large-scale production, thereby optimizing efficiency and output.

Career Highlights

Atul S. Kotnis is affiliated with Bristol-Myers Squibb Company, a global leader in biopharmaceuticals. His position at such a prominent organization underscores his expertise and the value of his contributions to drug discovery and development.

Collaborations

Throughout his career, Kotnis has collaborated with esteemed colleagues including John J. Venit and Jollie D. Godfrey, Jr. These teamwork dynamics foster an environment of shared knowledge and innovation, critical to advancing their collective research efforts.

Conclusion

Atul S. Kotnis stands out in the realm of chemical invention, with patented processes that not only facilitate efficient synthesis but also contribute to the broader field of medicinal chemistry. His work exemplifies how innovation can drive progress within the pharmaceutical industry, establishing a foundation for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…